|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 125.52 USD | +0.26% |
|
-2.99% | -7.82% |
| 04:01pm | JPMorgan Adjusts Price Target on Xylem to $160 From $170, Maintains Overweight Rating | MT |
| 14/04 | Stifel Adjusts Price Target on Xylem to $163 From $175, Maintains Buy Rating | MT |
Company Valuation: Xylem Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 21,625 | 19,927 | 27,570 | 28,186 | 33,156 | 30,439 | - | - |
| Change | - | -7.85% | 38.35% | 2.24% | 17.63% | -8.19% | - | - |
| Enterprise Value (EV) 1 | 22,716 | 20,863 | 28,835 | 29,081 | 33,619 | 30,304 | 29,447 | 28,739 |
| Change | - | -8.16% | 38.21% | 0.86% | 15.6% | -9.86% | -2.83% | -2.4% |
| P/E ratio | 51x | 56.4x | 41x | 31.8x | 34.7x | 27.5x | 24.1x | 20.6x |
| PBR | 6.72x | 5.7x | 2.72x | 2.65x | 2.89x | 2.49x | 2.4x | 2.38x |
| PEG | - | -3.4x | 1x | 1x | 4.69x | 1.7x | 1.7x | 1.2x |
| Capitalization / Revenue | 4.16x | 3.61x | 3.74x | 3.29x | 3.67x | 3.31x | 3.17x | 3.01x |
| EV / Revenue | 4.37x | 3.78x | 3.92x | 3.4x | 3.72x | 3.3x | 3.07x | 2.84x |
| EV / EBITDA | 26.5x | 23x | 20.7x | 16.5x | 16.7x | 14.2x | 12.8x | 11.5x |
| EV / EBIT | 37.2x | 31x | 26.9x | 21.2x | 20.9x | 17.6x | 15.5x | 13.8x |
| EV / FCF | 68.8x | 53.8x | 48.1x | 30.9x | 36.9x | 29x | 22.6x | 18.9x |
| FCF Yield | 1.45% | 1.86% | 2.08% | 3.24% | 2.71% | 3.45% | 4.43% | 5.28% |
| Dividend per Share 2 | 1.12 | 1.2 | 1.32 | 1.44 | - | 1.725 | 1.849 | 2.008 |
| Rate of return | 0.93% | 1.09% | 1.15% | 1.24% | - | 1.38% | 1.48% | 1.6% |
| EPS 2 | 2.35 | 1.96 | 2.79 | 3.65 | 3.92 | 4.552 | 5.205 | 6.083 |
| Distribution rate | 47.7% | 61.2% | 47.3% | 39.5% | - | 37.9% | 35.5% | 33% |
| Net sales 1 | 5,195 | 5,522 | 7,364 | 8,562 | 9,035 | 9,195 | 9,607 | 10,117 |
| EBITDA 1 | 856 | 908 | 1,392 | 1,763 | 2,009 | 2,127 | 2,304 | 2,509 |
| EBIT 1 | 611 | 672 | 1,072 | 1,373 | 1,612 | 1,725 | 1,899 | 2,085 |
| Net income 1 | 427 | 355 | 609 | 890 | 957 | 1,119 | 1,279 | 1,446 |
| Net Debt 1 | 1,091 | 936 | 1,265 | 895 | 463 | -134.4 | -991.5 | -1,700 |
| Reference price 2 | 119.92 | 110.57 | 114.36 | 116.02 | 136.18 | 125.19 | 125.19 | 125.19 |
| Nbr of stocks (in thousands) | 1,80,325 | 1,80,222 | 2,41,078 | 2,42,945 | 2,43,469 | 2,43,141 | - | - |
| Announcement Date | 03/02/22 | 07/02/23 | 06/02/24 | 04/02/25 | 10/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 27.5x | 3.3x | 14.25x | 1.38% | 3.04TCr | ||
| 35.78x | 6.08x | 22.4x | 0.75% | 12TCr | ||
| 35.69x | 6.04x | 22.71x | 1.71% | 3.62TCr | ||
| 31.54x | 4.43x | 16.26x | 0.1% | 3.27TCr | ||
| 23.38x | 3.52x | 15.03x | 0.99% | 2.9TCr | ||
| 28.54x | 4.7x | 16.82x | 1.4% | 2.86TCr | ||
| 18.4x | 1.5x | 11.13x | 2.63% | 2.61TCr | ||
| 26.04x | 3.3x | 16.01x | 1.74% | 2.51TCr | ||
| 30.83x | 2.67x | 17.46x | 1.74% | 2.45TCr | ||
| 48.61x | 12.22x | 37.76x | 0.77% | 2.04TCr | ||
| Average | 30.63x | 4.78x | 18.98x | 1.32% | 3.75TCr | |
| Weighted average by Cap. | 31.73x | 5.01x | 19.54x | 1.17% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- XYL Stock
- Valuation Xylem Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















